Issue link: http://osercommunicationsgroup.uberflip.com/i/808989
Chain Drugstore Daily 1 9 Sunday, April 23, 2017 2017 Best of Show BERRY SLEEPY & BERRY AWAKE: POWERED BY HEALTHY VENTURES Healthy Ventures has assembled a strong CPG Lean Team to aid or run up and coming branded companies. It creates strong innovative brands like Schiff Vitamins, Power Bar, Oral-B Products, Nestle Products, brand builder of No. 1 Freeze Dried Crunchies Naturals, the innovative Berry Sleepy and now Berry Awake. In November 2017, Berry Awake will be introducing Berry Awake Veg Caps in 24, 60, two usage blister pack and a single serve trial size. This mirrors the Berry Sleepy line up of delivery methods. As part of the expansion, the company is responding to retailer requests to add a 4-pack of Berry Sleepy Shots. This will provide an economy pur- chase when purchasing a 4-pack. Berry Sleepy is made up of a propri- etary sleep and relaxation blend; all-nat- ural tart cherries, passion fruit, goji berries and valerian root extract. The base of this formula is all berries with 5 grams of prebiotics. Berry Awake is made up of a propri- etary energy blend of green coffee berries extract, guarana seed extract, bacopa leaf extract and ginseng. In addition, the com- pany added 2000mg of pea protein. Products are kosher, non-GMO, vegan and Manufactured in USA. Berry Sleepy will come in 60-count bottle veg caps for $19.99 MSRP, 24- count at $9.99, One Single Serve 99 cents, Two Serving Blister Package at $2.39 and 2-ounce Berry Sleepy Shots in Strawberry and Mixed natural flavors for $3.99. Berry Awake will come in 2-ounce Berry Awake Shots and will be available in Strawberry and Mixed Berry natural flavors. They will be line priced with Berry Sleepy at $3.99 each. The new 4-pack will retail for $14.99 in both Strawberry and Mixed Berry, 60-count at $19.99, 24-count at $9.99, Single Serve at 99 cents and the Blister Package at $2.39. Berry Sleepy and Berry Awake launch at Expo West 2017, NACDS 2017, Expo East 2017 and NACS 2017. The products will be supported with a strong print campaign in various trade magazines this fall. The company will place major focus on the consumer with Modern Living with Kathy Ireland, Entertainment Television and Bloomberg International. On the topic of sleep innovations, the company will be interviewed by Kathy Ireland on Berry Sleepy and the innova- tion of Berry Awake. Supported with social media globally, the company will be on TV in all major markets beginning in October of 2017. Upcoming for the company are direct mail coupons and a new website in July 2017 with major focus on Facebook and other social media event campaigns. The company will also step up its marketing events with major sponsors of trade shows and focus on grassroots marketing events, both domestic and international, all focused on moving to a leadership posi- tion in the natural sleep category. For more information, email james@berrysleepy.com or james@ healthyventures.com, or call 805.601.7201 or 805.390.6274. BIONIK LABORATORIES ANNOUNCES OPTION TO LICENSE ROBOTICS TECHNOLOGY FROM THE UNIVERSITY OF TEXAS AT DALLAS Bionik Laboratories Corp., a robotics company focused on providing rehabil- itation and mobility solutions to indi- viduals with neurological and mobility challenges from hospital to home, announced that it has entered into an option agreement with The University of Texas at Dallas with respect to cer- tain UT Dallas' novel robotics and con- trol systems technologies. The agree- ment establishes a one-year period in which Bionik can evaluate these tech- nologies, and grants to Bionik an exclu- sive option to negotiate an exclusive, worldwide license under certain patent rights owned by UT Dallas, as well as an option to negotiate a non-exclusive license under certain technology rights owned by UT Dallas. Bionik is evaluat- ing these technologies to determine whether they can be used to enhance the company's planned assistive product line expansion. Bionik's robotic solutions are cur- rently contributing to effective and affordable patient care with respect to treatment of neurological disorders in 20 countries and in more than 240 hospitals. Exoskeletons serve as one of the compa- ny's primary focuses. Bionik has seven robotic products, of which three are FDA-cleared and in the market globally, and four products that are in various stages of development. Michal Prywata, Co-Founder, Chief Technology Officer and Director of Bionik, has stated, "Management is extremely pleased to forge this strategic relationship with the University of Texas at Dallas. Bionik has determined that possessing access to the world's leading robotic technology is para- mount to developing state-of-the-art robotics and establishing ourselves as a leader within the emerging medical device industry. We entered into this option agreement as our preliminary investigation has indicated that this infusion of technology and innovation will provide a strong, competitive advantage to our current technology platform, and that the company can extend its exoskeleton robotic platform and improve our existing technology." The technology has been developed by Dr. Robert Gregg IV and his two col- leagues, Ge Lv and Hanqi Zhu, and their robotics lab at UT Dallas. Dr. Gregg is an assistant professor of bio- engineering and mechanical engineer- ing, and the director of the Locomotor Control Systems Laboratory at UT Dallas and the UT Southwestern Medical Center. He was previously a research scientist at the Rehabilitation Institute of Chicago and a postdoctoral fellow at Northwestern University. His research and inventions concern the control mechanisms of human locomo- tion with applications to wearable and autonomous robots. For more information, visit www.bioniklabs.com.